zoledronic acid has been researched along with Chronic Kidney Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, MR; Aref, MW; Byiringiro, I; Chen, N; Dunn, KW; Hammond, MA; Kamocka, MM; McCarthy, BP; Moe, SM; Swallow, EA; Territo, PR; Winfree, S | 1 |
| David-Neto, E; Elias, RM; Marques, IDB; Moysés, RMA | 1 |
| Allen, MR; Aref, MW; Chen, N; Hammond, MA; Lehmkuhler, DR; Metzger, CE; Moe, SM; Nickolas, TL; Sacks, S; Swallow, EA; Territo, PR | 1 |
| Aschauer, L; Crean, D; Hewitt, P; Jennings, P; Kern, G; Leonard, MO; Lhotta, K; Limonciel, A; Lukas, A; Moenks, K; Wilmes, A | 1 |
| Allen, MR; Brown, D; Carr, AJ; Chen, NX; Chen, X; Gattone, VH; LeBlanc, P; Moe, SM | 1 |
5 other study(ies) available for zoledronic acid and Chronic Kidney Diseases
| Article | Year |
|---|---|
Skeletal accumulation of fluorescently tagged zoledronate is higher in animals with early stage chronic kidney disease.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Disease Models, Animal; Male; Optical Imaging; Rats, Inbred Strains; Renal Insufficiency, Chronic; Tibia; Zoledronic Acid | 2018 |
Authors' Reply.
Topics: Humans; Kidney Transplantation; Renal Insufficiency, Chronic; Zoledronic Acid | 2019 |
Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosing.
Topics: Animals; Body Weight; Bone and Bones; Bone Remodeling; Diphosphonates; Dose-Response Relationship, Drug; Fluorescence; Male; Osteogenesis; Rats; Renal Insufficiency, Chronic; Tibia; Zoledronic Acid | 2019 |
Interleukin-19 as a translational indicator of renal injury.
Topics: Biomarkers; Cell Culture Techniques; Cell Line; Diphosphonates; Gene Expression Regulation; Humans; Imidazoles; Interleukins; Kidney Tubules, Proximal; Renal Insufficiency, Chronic; Zoledronic Acid | 2015 |
Skeletal effects of zoledronic acid in an animal model of chronic kidney disease.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diaphyses; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Drug; Femur; Imidazoles; Male; Osteogenesis; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Tibia; Zoledronic Acid | 2013 |